BioMarin to Attend Upcoming Investor Conference

SAN RAFAEL, Calif., May 2, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaim√©, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch Health Care Conference on May 15, 2018 at 10:40am PT/1:40pm ET in Las Vegas. To access the live webcast, please visit the investor section of the BioMarin website, A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit Information on BioMarin's website is not incorporated by reference into this press release.


    Investors                                  Media

    Traci McCarty                              Debra Charlesworth

    BioMarin Pharmaceutical Inc.               BioMarin Pharmaceutical Inc.

    (415) 455-7558                             (415) 455-7451




View original content with multimedia:

SOURCE BioMarin Pharmaceutical Inc.

Back to news